Literature DB >> 9018871

Antibodies against HIV-1 from phage display libraries: mapping of an immune response and progress towards antiviral immunotherapy.

P W Parren1, D R Burton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9018871     DOI： 10.1159/000319346

Source DB:  PubMed          Journal:  Chem Immunol        ISSN： 0079-6034


× No keyword cloud information.
  15 in total

1.  Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity.

Authors:  P W Parren; I Mondor; D Naniche; H J Ditzel; P J Klasse; D R Burton; Q J Sattentau
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

2.  Cloning the antibody response in humans with chronic inflammatory disease: immunopanning of subacute sclerosing panencephalitis (SSPE) brain sections with antibody phage libraries prepared from SSPE brain enriches for antibody recognizing measles virus antigens in situ.

Authors:  G P Owens; R A Williamson; M P Burgoon; O Ghausi; D R Burton; D H Gilden
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Human antibodies against spores of the genus Bacillus: a model study for detection of and protection against anthrax and the bioterrorist threat.

Authors:  Bin Zhou; Peter Wirsching; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

4.  In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type 1 envelope.

Authors:  P W Parren; P Fisicaro; A F Labrijn; J M Binley; W P Yang; H J Ditzel; C F Barbas; D R Burton
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

Authors:  M B Zwick; A F Labrijn; M Wang; C Spenlehauer; E O Saphire; J M Binley; J P Moore; G Stiegler; H Katinger; D R Burton; P W Parren
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodies.

Authors:  N Sullivan; Y Sun; J Binley; J Lee; C F Barbas; P W Parren; D R Burton; J Sodroski
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

7.  An HIV-1 envelope glycoprotein trimer with an embedded IL-21 domain activates human B cells.

Authors:  Gözde Isik; Nancy P Y Chung; Thijs van Montfort; Sergey Menis; Katie Matthews; William R Schief; John P Moore; Rogier W Sanders
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

8.  Autoantibodies induced by chimeric cytokine-HIV envelope glycoprotein immunogens.

Authors:  Gözde Isik; Thijs van Montfort; Nancy P Y Chung; John P Moore; Rogier W Sanders
Journal:  J Immunol       Date:  2014-04-11       Impact factor: 5.422

9.  Chimeric HIV-1 envelope glycoproteins with potent intrinsic granulocyte-macrophage colony-stimulating factor (GM-CSF) activity.

Authors:  Gözde Isik; Thijs van Montfort; Maikel Boot; Viviana Cobos Jiménez; Neeltje A Kootstra; Rogier W Sanders
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

10.  Antibody neutralization-resistant primary isolates of human immunodeficiency virus type 1.

Authors:  P W Parren; M Wang; A Trkola; J M Binley; M Purtscher; H Katinger; J P Moore; D R Burton
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.